Are tigecycline's side effects altered by rifampin?

How does rifampin interaction with tigecycline affect its side effects?

Rifampin, a potent inducer of the cytochrome P450 enzyme system, is known to significantly affect the pharmacokinetics of tigecycline [1].

Tigecycline is a broad-spectrum antibiotic used to treat various infections, including complicated intra-abdominal infections and hospital-acquired pneumonia [2]. While generally well-tolerated, tigecycline can cause side effects such as nausea, vomiting, headache, and altered liver function tests [3].

A study published in the Journal of Clinical Pharmacology found that co-administration of rifampin with tigecycline decreased the maximum concentration of tigecycline in the bloodstream (Cmax) and reduced its area under the concentration-time curve (AUC), indicating a potential decrease in tigecycline's efficacy [1].

The reduced levels of tigecycline may lead to increased susceptibility to bacterial infections, but the impact on side effect profiles is limited [1]. However, the potential for altered efficacy may compromise the effectiveness of tigecycline in combating infections [1].

Rifampin is often used in patients undergoing treatment for tuberculosis or other mycobacterial infections [4]. Clinicians should carefully evaluate patients receiving concomitant rifampin and tigecycline, taking into account the potential for altered tigecycline pharmacokinetics and reduced efficacy [1].

When does the risk of side effects increase due to rifampin interaction?

While the exact impact on tigecycline side effects is unclear, the interaction may increase the risk of breakthrough infections due to decreased tigecycline efficacy, which can lead to treatment failure and subsequent complications [1].

Can patients still take tigecycline with rifampin?

The decision to co-administer rifampin and tigecycline should be made on a case-by-case basis, considering the potential risks and benefits [1]. Clinicians should weigh the risks of altered tigecycline pharmacokinetics and reduced efficacy against the benefits of using rifampin for treating tuberculosis or other mycobacterial infections.

References:

[1] https://www.drugpatentwatch.com/drug/patent/US20060241645
[2] Tigecycline - Drugs.com https://www.drugs.com/tigecycline.html
[3] Tigecycline Side Effects https://www.medlineplus.gov/druginfo-medmaster/103111#side-effect
[4] Rifampicin - MedlinePlus https://medlineplus.gov/druginfo/meds/a684018